Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00450320 · ClinicalTrials.gov registry record · Phase 1
Sirolimus in Treating Patients With HIV-Related Kaposi's Sarcoma
A Phase 1 study, sponsored by AIDS Malignancy Consortium.
- Completed
- Registry status
- Phase 1
- Development phase
- 7
- Enrollment target
NCT00450320: Completed Phase 1 study, sponsored by AIDS Malignancy Consortium.
NCT00450320 is a Phase 1 study that has completed, run by AIDS Malignancy Consortium. The registered enrollment target is 7 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00450320, a Phase 1 study, has completed, sponsored by AIDS Malignancy Consortium.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 7 participants
- Enrollment target
Study Summary
RATIONALE: Drugs used in chemotherapy, such as sirolimus, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Sirolimus also may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor. PURPOSE: This pilot study is studying sirolimus in treating patients with HIV-related Kaposi's sarcoma.
Interventions
- DRUG sirolimus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2007-10 |
| Est. Completion | 2009-09 |
| Phase | Phase 1 |
What the finished NCT00450320 record still lists
NCT00450320 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 1 intervention - of which sirolimus is the first listed.
NCT00450320 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00450320 about?
NCT00450320 is a clinical study titled "Sirolimus in Treating Patients With HIV-Related Kaposi's Sarcoma". RATIONALE: Drugs used in chemotherapy, such as sirolimus, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Sirolimus also may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking ...
What is the current status of trial NCT00450320?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 7 participants. The study started on 2007-10. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00450320?
The interventions under investigation include: sirolimus (DRUG).
Who is sponsoring clinical trial NCT00450320?
This trial is sponsored by AIDS Malignancy Consortium, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00450320's enrollment target sits among peer trials
7 1972nd of 2000 higher than 27 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia